Funded Startups in Carmel
Across the 20 most recent Carmel-area funding entries shown, the largest disclosed round is Kinetic Advantage’s $225M (2026-01-29).
Across the 20 most recent Carmel-area funding entries shown, the largest disclosed round is Kinetic Advantage’s $225M (2026-01-29). That figure dwarfs the next-largest disclosed amount: $115M for Assembly Biosciences (2026-05-22), followed by $64M for MBX Biosciences (2024-08-05); the remaining disclosed rounds mostly sit far below $50M, including multiple at $36M (Acumen Pharmaceuticals on 2026-03-16) and $25M (Gate Neurosciences on 2022-10-05). The list also shows a clear temporal clustering near the present: 7 of the 20 rows are dated between 2026-05-12 and 2026-03-16 (Assembly Biosciences, Quantasonix Technologies, Acumen Pharmaceuticals, Spektrum, and Kinetic Advantage), while the oldest shown entry is Realync in Carmel, Indiana on 2020-12-03.
Sector and stage signals concentrate around repeats and classification gaps. Biotechnology appears in 4 entries (Assembly Biosciences 2026-05-22, Acumen Pharmaceuticals 2026-03-16, MBX Biosciences 2024-08-05, Gate Neurosciences 2022-10-05). “Series Unknown” is the most common disclosed classification, appearing in 10 of 20 rows, and “undisclosed” amounts appear in 4 rows (Reveleum on 2025-03-06; Cosmo’s Superior Foods on 2024-01-18; WalkerHughes Insurance on 2023-09-18; illuminate.health on 2023-03-15). Geographic patterns are predominantly Carmel, Indiana, with one Carmel, California entry (NutJobs on 2023-01-06).
Most recent rounds
20 shownRelated listings
Frequently asked
What’s the largest disclosed round in Carmel here, and is it an outlier versus the rest?
Kinetic Advantage’s $225M (2026-01-29) is the only disclosed round above $115M; the next-largest disclosed amount is $115M for Assembly Biosciences (2026-05-22), with MBX Biosciences at $64M (2024-08-05) trailing the top two.
Do the most recent rounds cluster tightly in time?
Yes. Five of the 20 entries fall in a short late-spring 2026 window, from 2026-05-12 (Quantasonix Technologies $2M) through 2026-05-22 (Assembly Biosciences $115M), and more broadly 7 entries are dated between 2026-05-12 and 2026-03-16.
Which sectors show up repeatedly in this Carmel set?
Biotechnology is the most repeated sector with 4 entries: Assembly Biosciences (2026-05-22, $115M), Acumen Pharmaceuticals (2026-03-16, $36M), MBX Biosciences (2024-08-05, $64M), and Gate Neurosciences (2022-10-05, $25M).
How much of the list is labeled with missing or non-specific funding info (Series Unknown or undisclosed)?
Classification is sparse: “Series Unknown” appears in 10 of 20 rows (for example, Spektrum on 2026-02-24 at $7M and Syra Health on 2024-09-11 at $2M), and “undisclosed” amounts appear in 4 rows (Reveleum 2025-03-06; Cosmo’s Superior Foods 2024-01-18; WalkerHughes Insurance 2023-09-18; illuminate.health 2023-03-15).
Are there notable geography exceptions within the Carmel results?
The set is overwhelmingly Carmel, Indiana, but one row breaks the pattern: NutJobs is listed as Carmel, California with a disclosed $9M on 2023-01-06, while the other 19 entries cite Carmel, Indiana.
What does the stage mix look like around the most recent years, based on disclosed labels?
Seed appears multiple times in the recent entries (Quantasonix Technologies 2026-05-12 at $2M; Reveleum 2025-03-06 is undisclosed; NeurAxis is listed without a specific series on 2025-05-21 at $5M), while specific labeled stages also show up as isolated cases like Series C for MBX Biosciences ($64M, 2024-08-05) and Series A for Your Money Line ($5M, 2024-08-16).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.